Treatment of the lymph node cancer called diffuse large B-cell lymphoma is all-or-nothing. Chemotherapy cures about 40 percent of patients, but the others eventually die from this cancer. Because of that split, scientists deduce that the cancer cells–although outwardly similar–must vary from patient to patient.
The lymphoma arises in immune cells that reside in lymph nodes, and it causes tumors there.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.